Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Eur Urol ; 2024 Apr 30.
Article in English | MEDLINE | ID: mdl-38692956

ABSTRACT

BACKGROUND: Conventionally, standard resection (SR) is performed by resecting the bladder tumour in a piecemeal manner. En bloc resection of the bladder tumour (ERBT) has been proposed as an alternative technique in treating non-muscle-invasive bladder cancer (NMIBC). OBJECTIVE: To investigate whether ERBT could improve the 1-yr recurrence rate of NMIBC, as compared with SR. DESIGN, SETTING, AND PARTICIPANTS: A multicentre, randomised, phase 3 trial was conducted in Hong Kong. Adults with bladder tumour(s) of ≤3 cm were enrolled from April 2017 to December 2020, and followed up until 1 yr after surgery. INTERVENTION: Patients were randomly assigned to receive either ERBT or SR in a 1:1 ratio. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The primary outcome was 1-yr recurrence rate. A modified intention-to-treat analysis on patients with histologically confirmed NMIBC was performed. The main secondary outcomes included detrusor muscle sampling rate, operative time, hospital stay, 30-d complications, any residual or upstaging of disease upon second-look transurethral resection, and 1-yr progression rate. RESULTS AND LIMITATIONS: A total of 350 patients underwent randomisation, and 276 patients were histologically confirmed to have NMIBC. At 1 yr, 31 patients in the ERBT group and 46 in the SR group developed recurrence; the Kaplan-Meier estimate of 1-yr recurrence rates were 29% (95% confidence interval, 18-37) in the ERBT group and 38% (95% confidence interval, 28-46) in the SR group (p = 0.007). Upon a subgroup analysis, patients with 1-3 cm tumour, single tumour, Ta disease, or intermediate-risk NMIBC had a significant benefit from ERBT. None of the patients in the ERBT group and three patients in the SR group developed progression to muscle-invasive bladder cancer; the Kaplan-Meier estimates of 1-yr progression rates were 0% in the ERBT group and 2.6% (95% confidence interval, 0-5.5) in the SR group (p = 0.065). The median operative time was 28 min (interquartile range, 20-45) in the ERBT group and 22 min (interquartile range, 15-30) in the SR group (p < 0.001). All other secondary outcomes were similar in the two groups. CONCLUSIONS: In patients with NMIBC of ≤3 cm, ERBT resulted in a significant reduction in the 1-yr recurrence rate when compared with SR (funded by GRF/ECS, RGC, reference no.: 24116518; ClinicalTrials.gov number, NCT02993211). PATIENT SUMMARY: Conventionally, non-muscle-invasive bladder cancer is treated by resecting the bladder tumour in a piecemeal manner. In this study, we found that en bloc resection, that is, removal of the bladder tumour in one piece, could reduce the 1-yr recurrence rate of non-muscle-invasive bladder cancer.

2.
Asia Pac J Clin Oncol ; 17 Suppl 3: 48-54, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33860643

ABSTRACT

AIM: In response to the fast-developing coronavirus disease 2019 (COVID-19) pandemic, special arrangement and coordination are urgently required in the interdisciplinary care of patients across different medical specialties. This article provides recommendations on the management of different stages of localized or metastatic prostate cancer (PC) amid this pandemic. METHODS: The Hong Kong Urological Association and Hong Kong Society of Uro-oncology formed a joint discussion panel, which consisted of six urologists and six clinical oncologists with extensive experience in the public and private sectors. Following an evidence-based approach, the latest relevant publications were searched and reviewed, before proceeding to a structured discussion of relevant clinical issues. RESULTS: The joint panel provided recommendations for PC management during the pandemic, in terms of general considerations, diagnostic procedures, different disease stages, treatment modules, patient support, and interdisciplinary collaboration. The overall goal was to minimize the risk of infection while avoiding unnecessary delays and compromises in management outcomes. Practical issues during the pandemic were addressed such as the use of invasive diagnostic procedures, robotic-assisted laparoscopic prostatectomy, hypofractionated radiotherapy, and prolonged androgen deprivation therapy. The recommendations were explicated in the context of Hong Kong, a highly populated international city, in relation to the latest international guidelines and evidence. CONCLUSION: A range of recommendations on the management of PC patients during the COVID-19 pandemic was developed. Urologists, oncologists, and physicians treating PC patients may refer to them as practical guidance.


Subject(s)
COVID-19/epidemiology , Prostatic Neoplasms/therapy , SARS-CoV-2 , Androgen Antagonists/therapeutic use , Hong Kong/epidemiology , Humans , Male , Medical Oncology , Prostatectomy , Prostatic Neoplasms/pathology , Societies, Medical
3.
Asia Pac J Clin Oncol ; 17 Suppl 3: 12-26, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33860645

ABSTRACT

BACKGROUND: To update the Hong Kong Urological Association-Hong Kong Society of Uro-Oncology consensus statements on the management of advanced prostate cancer, the same panelists as in the previous consensus panel held a series of meetings to discuss updated clinical evidence and experiences. METHODS: The previous consensus statements were retained, deleted, or revised, and new statements were added. At the final meeting, all statements were reviewed and amended as appropriate, followed by panel voting. RESULTS: There were significant changes and additions to the previous consensus statements, primarily driven by the advances in androgen receptor signaling inhibitors, treatment sequencing in metastatic castration-resistant prostate cancer, and increasing recognition of oligometastatic prostate cancer since the introduction of prostate-specific membrane antigen positron emission tomography. In this update, a total of 59 consensus statements were accepted and established. CONCLUSIONS: The consensus panel updated consensus statements on the management of advanced prostate cancer, aiming to allow physicians in the region to keep abreast of the recent evidence on optimal clinical practices.


Subject(s)
Prostatic Neoplasms/therapy , Urology/methods , History, 21st Century , Hong Kong , Humans , Male , Prostatic Neoplasms/pathology
4.
Urol Case Rep ; 23: 87-89, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30719408

ABSTRACT

Penile strangulation by penile constriction devices present uncommonly but require urgent intervention to minimize risk of penile injuries. Non-invasive methods can be attempted and have been proven successful in previous case reports. Surgical intervention with use of cutting tools should be considered if non-invasive means fail. We present a case of penile strangulation by a metal hex nut with successful removal using a Stryker diamond disc cutter. Despite residual scarring with retracted prepuce, the patient could void well and had normal erection on follow up at 1 month and 6 months.

5.
BJU Int ; 124(2): 221-241, 2019 08.
Article in English | MEDLINE | ID: mdl-30653801

ABSTRACT

OBJECTIVE: To formulate consensus statements to facilitate physician management strategies for patients with clinically localized prostate cancer (PCa) in Hong Kong by jointly convening a panel of 12 experts from the two local professional organizations representing PCa specialists, who had previously established consensus statements on the management of metastatic PCa for the locality. METHODS: Through a series of meetings, the panellists discussed their clinical experience and the published evidence regarding various areas of the management of localized PCa, then drafted consensus statements. At the final meeting, each drafted statement was voted on by every panellist based on its practicability of recommendation in the locality. RESULTS: A total of 76 consensus statements were ultimately accepted and established by panel voting. CONCLUSION: Derived from the recent evidence and major overseas guidelines, along with local clinical experience and practicability, the consensus statements were aimed to serve as a practical reference for physicians in Hong Kong for the management of localized PCa.


Subject(s)
Prostatic Neoplasms/pathology , Prostatic Neoplasms/therapy , Consensus , Hong Kong , Humans , Male , Prostatic Neoplasms/diagnostic imaging
6.
BJU Int ; 121(5): 703-715, 2018 05.
Article in English | MEDLINE | ID: mdl-29211320

ABSTRACT

To establish a set of consensus statements to facilitate physician management strategies for patients with metastatic prostate cancer (mPCa) in Hong Kong. A local expert consensus was organized jointly by the two main professional organizations representing prostate cancer specialists in Hong Kong. A total of 12 experts were included in the consensus panel. Six of the most crucial and relevant areas of debate regarding the management of mPCa were identified. With the use of a modified Delphi method, several panel meetings were held for the members to discuss their clinical experience and the published literature relevant to the areas of debate. At the final meeting, each drafted statement was voted on by every member based on its practicability of recommendation in the locality. After the panel voting, a total of 45 consensus statements regarding the management of mPCa were ultimately accepted and established. The consensus statements were primarily derived from the latest clinical evidence and major overseas guidelines, with the consideration of local clinical experience and practicability. These are considered applicable recommendations for Hong Kong physicians for the management of mPCa patients.


Subject(s)
Neoplasm Metastasis/pathology , Neoplasm Metastasis/therapy , Prostatic Neoplasms/pathology , Prostatic Neoplasms/therapy , Urology , Angiogenesis Inhibitors , Antineoplastic Agents , Biomarkers, Tumor , Disease Management , Gene Expression Regulation, Neoplastic , Hong Kong , Humans , Male , Practice Guidelines as Topic , Practice Patterns, Physicians' , Survival Rate
7.
Aging Male ; 20(4): 241-249, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28787255

ABSTRACT

PURPOSE: To test the psychometric properties of the International Prostate Symptom Score (Hong Kong Chinese version 2) (IPSS) in Chinese male patients with benign prostatic hyperplasia (BPH) under secondary care. METHODS: A prospective longitudinal study was done by interviewing subjects at baseline, at 2 week after baseline for assessing test-retest reliability and at 26 week after baseline for assessing responsiveness. All subjects were interviewed to complete a structured questionnaire including IPSS, Short Form-12 Health Survey version 2 (SF-12v2) and Depression Anxiety Stress Scale (DASS). RESULTS: The IPSS HRQOL score had weak correlations with SF-12v2 summary and DASS domain scores. For reliability analysis, Cronbach's alpha coefficient was 0.90 for the seven symptom-related items. The intraclass correlation coefficients of the IPSS total symptom score and HRQOL score were 0.90 and 0.86, respectively. For sensitivity, statistically significant differences were detected between the subjects with BPH and those without for IPSS total symptom score (effect size = 0.68) but not the IPSS HRQOL score. The areas under ROC curves for the IPSS total symptom and HRQOL scores were 0.67 and 0.60, respectively. CONCLUSIONS: The IPSS was valid, reliable instrument in Chinese patients with BPH. The IPSS total symptom score, but not the HRQOL score, is sensitive in differentiating subgroups.


Subject(s)
Health Surveys , Prostatic Hyperplasia/psychology , Quality of Life , Aged , Anxiety/complications , Case-Control Studies , Depression/complications , Hong Kong , Humans , Longitudinal Studies , Male , Middle Aged , Prospective Studies , Prostatic Hyperplasia/complications , Prostatic Hyperplasia/physiopathology , Psychometrics , Reproducibility of Results , Stress, Psychological/complications
8.
J Endourol ; 30(2): 160-4, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26414736

ABSTRACT

OBJECTIVE: Traditionally, fluoroscopy or ultrasound (US) or both are used for guiding tract creation during percutaneous nephrolithotomy (PCNL). However, the use of fluoroscopy inevitably incurs radiation exposure, which should be cut down as much as possible in view of its potential adverse effects on health: both deterministic effects and stochastic effects. Conventional US guidance, being radiation free, can serve the purpose, but it is difficult to visualize the needle tract during screening without a needle-guiding system fixed to the transducer, and hence, there is a lack of predictability and sense of security. The objective of this study is to assess the feasibility of using US with navigation system (USNS) to solve the above problems. PATIENTS AND METHODS: In 2014, we performed PCNL on 18 patients with USNS guidance. During the puncture step, the magnetic field-based navigation US could help visualize the position of the needle tract in relation to the target calix. The procedure was done in free hand without the usage of needle-guiding system attached to the transducer. Needle deviation could be detected and adjusted immediately to achieve precise puncture. RESULTS: Of the 18 patients, 83.3% (15/18) of them had their punctures effectively done with a single attempt. Three puncture procedures were performed by two urologic trainees without any previous USNS experience. The mean fluoroscopy time during dilatation was 74.6s, with no radiation at all during the puncture step. The stone clearance rate was 72.2%, with 66.7% (12/18) being tubeless procedures. The mean length of hospital stay was 4.8 days. No immediate complications related to the puncture procedure were found. CONCLUSIONS: USNS can provide radiation-free guidance for tract creation in PCNL. It is predictable, precise, reliable, and safe. Most importantly, the technique is easy to learn, particularly for urologists who are new to PCNL.


Subject(s)
Kidney Calculi/surgery , Kidney/surgery , Magnetic Fields , Nephrostomy, Percutaneous/methods , Surgery, Computer-Assisted/methods , Adult , Aged , Cohort Studies , Female , Fluoroscopy , Hong Kong , Humans , Kidney/diagnostic imaging , Kidney Calculi/diagnostic imaging , Length of Stay , Male , Middle Aged , Needles , Prospective Studies , Punctures , Transducers , Ultrasonography , Urology
9.
Urol Int ; 94(1): 31-6, 2015.
Article in English | MEDLINE | ID: mdl-25059529

ABSTRACT

OBJECTIVE: To review a series of inflammatory myofibroblastic tumours (IMTs) of the urinary bladder in 10 hospitals in Hong Kong. METHODS: A database search in the pathology archives of 10 hospitals in Hong Kong from 1995 to 2013 was performed using the key words 'inflammatory myofibroblastic tumour', 'inflammatory pseudotumour' and 'spindle cell lesion'. Patient characteristics, clinical features, histological features, immunohistochemical staining results and treatment outcomes were reviewed. RESULTS: Nine cases of IMT of the urinary bladder were retrieved. The mean age was 45.4 ± 22.8 years (range 11-78). Eight patients (88.9%) presented with haematuria and 5 patients (55.6%) had anaemia with a mean haemoglobin level of 6.8 ± 1.3 g/dl. Histologically, the majority of patients (77.8%) had a compact spindle cell pattern. Anaplastic lymphoma kinase staining was positive in 75% of cases. During a mean follow-up period of 43.4 months (range 8-94), none of them developed any local recurrence or distant metastasis. CONCLUSIONS: A high index of suspicion of IMT should be maintained for young patients presenting with bleeding bladder tumours and significant anaemia. IMTs of the urinary bladder run a benign disease course, and good prognosis can be achieved after surgical resection.


Subject(s)
Granuloma, Plasma Cell , Urinary Bladder Diseases , Adolescent , Adult , Aged , Anaplastic Lymphoma Kinase , Anemia/etiology , Biomarkers/analysis , Biopsy , Child , Cystectomy , Cystoscopy , Databases, Factual , Female , Granuloma, Plasma Cell/complications , Granuloma, Plasma Cell/metabolism , Granuloma, Plasma Cell/pathology , Granuloma, Plasma Cell/surgery , Hematuria/etiology , Hong Kong , Humans , Immunohistochemistry , Male , Middle Aged , Predictive Value of Tests , Receptor Protein-Tyrosine Kinases/analysis , Time Factors , Treatment Outcome , Urinary Bladder Diseases/complications , Urinary Bladder Diseases/metabolism , Urinary Bladder Diseases/pathology , Urinary Bladder Diseases/surgery , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...